Neurologic complications of transplantation

Neurologist

Volumn 8, Issue 2, 2002, Pages 107-120

  Pless, Misha ^a   Zivkovic, Sasha A ^a  

^a University of Pittsburgh School of Medicine   (United States)

Author keywords

Immunosuppression; Infection; Seizure; Stroke; Transplantation

Indexed keywords

ANTACID AGENT; ANTICONVULSIVE AGENT; ANTIFUNGAL AGENT; BARBITURIC ACID DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; CHLORAMPHENICOL; COLESTYRAMINE; CORTICOSTEROID; CYCLOSPORIN A; DANAZOL; DIGOXIN; ETOPOSIDE; IMMUNOSUPPRESSIVE AGENT; MACROLIDE; MIDAZOLAM; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NEFAZODONE; NELFINAVIR; OKT 3; OMEPRAZOLE; QUININE; RAPAMYCIN; RIFAMPICIN; SULFONAMIDE; TACROLIMUS; TERBINAFINE; TETRAHYDROLIPSTATIN; TROGLITAZONE; UNINDEXED DRUG;

BRAIN HEMORRHAGE; BRAIN TUMOR; CENTRAL NERVOUS SYSTEM INFECTION; DISEASE COURSE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; METABOLIC ENCEPHALOPATHY; MOTOR DYSFUNCTION; NEUROLOGICAL COMPLICATION; NEUROTOXICITY; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; REVIEW; SEIZURE; STROKE; SURVIVAL; VISUAL DISORDER;

EID: 0036201798     PISSN: 10747931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00127893-200203000-00005     Document Type: Review

References (137)

1. Neurological complications of bone marrow transplantation
2. Neurologic complications of pancreatic transplantation
3. Neurologic complications of cardiac transplantation
4. Neurological complications following liver transplantation
5. Neurological complications of liver transplantation in adult versus pediatric patients
6. Neurological complications of organ transplantation
7. Neurologic complications of autologous and allogeneic bone marrow transplantation with leukemia
8. Early neurologic complications following allogeneic bone marrow transplant for leukemia
9. Central nervous system complications after lung transplantation
10. The neuropathology of organ transplantation: Comparison and contrast in 500 patients
11. The neurology and neuropathology of hepatobiliary and pancreatic transplantation
12. Neurologic complications of pediatric lung transplantation
13. Central nervous system complications in liver transplant recipients - Incidence, timing and long-term follow-up
14. Neurological complications of small bowel transplantation
15. The neuropathology of liver transplantation: Comparison of main complications in children and adults
16. Seizures after liver transplantation: A clinicopathological study
17. Epileptiform electroencephalographic abnormalities in liver transplant recipients
18. Seizures after liver transplantation
19. Causes and outcomes of seizures in liver transplant recipients
20. Infection of the central nervous system in organ transplant recipients
21. Infection in the renal transplant recipient
22. Central nervous system complications in renal transplant recipients in a tropical environment
23. Central nervous system infections
24. Probable transmission of Toxoplasma gondii by organ transplantation
25. Demyelinating disorders
26. Failure of cytarabine in progressive multifocal encephalopathy associated with human immunodeficiency virus infection
27. Fungal infections of the central nervous system
28. Incidence and significance of Aspergillus cultures following liver and kidney transplantation
29. Aspergillosis of the central nervous system: Clinicopathological analysis of 17 patients
30. CNS aspergillosis in organ transplantation: A clinicopathological study
31. Cryptococcal meningitis in solid organ transplant recipients in a tertiary care center
32. Use of thallium-201 brain SPECT to differentiate cerebral lymphoma from toxoplasma encephalitis in AIDS patients
33. Acanthoamebiasis and immunosuppression. Case report
34. Opportunistic strongyloidiasis in renal transplant recipients
35. Stroke in renal transplant recipients
36. Progression of macrovascular disease after transplantation
37. Incidence of new-onset hypercholesterolemia in renal transplant patients treated with FK506 or cyclosporine
38. The effect of conversion from cyclosporine to tacrolimus on gingival hyperplasia, hirsutism and cholesterol
39. High frequency of antithrombin 3 and protein C deficiency following autologous bone marrow transplantation for lymphoma
40. Blood coagulation in uremic patients before and after hemodialysis and transplantation of the kidney
41. Postrenal transplant erythrocytosis: A review of 53 patients
42. The neurological complications of cardiac transplantation
43. Acute neurological complications after liver transplantation with particular reference to intraoperative cerebral air embolus
44. Cerebral infarction associated with protein C deficiency following allogenic bone marrow transplantation
45. Cerebrovascular complications after orthotopic liver transplantation
46. Intracerebral hemorrhage in liver transplant recipients
47. Intracranial hematoma after bone marrow transplantation
48. Cerebral hemorrhage in recipients of renal transplantation
49. Intracerebral hemorrhage complicating cardiac transplantation: Hyperperfusion breakthrough
50. Impaired consciousness after liver transplantation
51. The neurological complications of sepsis
52. Idiopathic hyperammonemia: A frequently lethal complication of bone marrow transplantation
53. Central pontine myelinolysis with stupor alone after orthotopic liver transplantation
54. Central pontine myelinolysis after liver transplantation
55. Rejection encephalopathy. An acute neurological syndrome complicating renal transplantation
56. Central nervous system toxicity after liver transplantation. Role of cyclosporine and cholesterol
57. Complications and monitoring of OKT3 therapy
58. Neurologic complications of FK 506
59. FK-506-induced neurotoxicity in liver transplantation
60. Neurotoxicity in liver transplant patients with cyclosporine immunosuppression
61. Oral cyclosporine decreases severity of neurotoxicity in liver transplant recipients
62. Calcineurin and the biological effect of cyclosporine and tacrolimus
63. Cyclosporin A in patients receiving renal allografts from cadaver donors
64. Severe bilateral tremor in a liver transplant recipient taking cyclosporine
65. Muscle disorders associated with cyclosporine treatment
66. FK506 promotes functional recovery in crushed rat sciatic nerve
67. Cyclosporin-associated akinetic mutism and extrapyramidal syndrome after liver transplantation
68. Expressive dysphasia possibly related to FK506 in two liver transplant recipients
69. Acute myopathy after liver transplantation
70. Causes of neuromuscular weakness in the intensive care unit: A study of ninety-two patients
71. Epidural lipomatosis in steroid-treated patients
72. Release of tumor necrosis factor, interleukin-2, and γ-interferon in serum after injection of OKT3 monoclonal antibody in kidney transplant recipients
73. Clinically significant drug interactions with new immunosuppressive agents
74. Statins after cardiac transplantation: Which statin, what dose, and how low should we go?
75. Acute onset of colchicine myoneuropathy in cardiac transplant recipients: Case studies of three patients
76. Acute myopathy induced by colchicine in a cyclosporine treated heart transplant recipient: Possible role of multidrug resistance transporter
77. Neurological complications of radiotherapy and chemotherapy
78. Posttransplant malignancies
79. Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting
80. Risk of lymphoproliferative disorders after bone marrow transplantation: A multi-institutional study
81. Post-transplant malignancy. The role of immunosuppression
82. Therapy for transplant-related lymphoproliferative disease
83. Parkinsonism during cyclosporine treatment
84. Cyclosporin A attenuates degeneration of dopaminergic neurons induced by 6-hydroxydopamine in the mouse brain
85. Steroid-responsive chorea in childhood following cardiac transplantation
86. A 10-year experience with postpump chorea
87. Abnormal movements in case of extrapontine myelinolysis. Review of the literature
88. Cortical blindness: A rare complication of cyclosporine therapy
89. Complex visual hallucinations and cyclosporine neurotoxicity
90. Cyclosporine-induced retinal toxic blindness
91. A case of bilateral optic neuropathy in the patient on a tacrolimus (FK-506) therapy after liver transplantation
92. Eye movement disorders in bone marrow transplant patients on cyclosporin and ganciclovir
93. Ocular involvement in patients with posttransplant lymphoproliferative disorder
94. Long-term effects of pancreatic transplantation on diabetic neuropathy
95. The course and prognostic factors of familial amyloid polyneuropathy after liver transplantation
96. Femoral neuropathy after renal transplantation
97. Incidence of phrenic neuropathy after isolated lung transplantation
98. Mononeuropathies associated with liver transplantation
99. Neuromuscular complications associated with liver transplantations
100. Brachial plexus injury following liver transplantation
101. Spectrum of neurologic events following cardiac transplantation
102. Iliac artery pseudoaneurysm following renal transplantation presenting as lumbosacral plexopathy
103. Polyneuropathy complicating bone marrow and solid organ transplantation
104. Guillain-Barré syndrome following allogeneic bone marrow transplantation
105. Guillain-Barré syndrome in immunocompromised patients: A report of three patients and review of the literature
106. Chronic inflammatory demyelinating polyneuropathy complicating liver transplantation
107. Sensorimotor neuropathy resembling CIDP in patients receiving FK506
108. Myopathy and prolonged neuromuscular blockade after lung transplant
109. Myasthenia gravis after allogeneic bone marrow transplantation: Relationship to chronic graft-versus-host-disease
110. Myasthenia gravis after allogeneic bone marrow transplantation: Report of a new case and pathogenetic considerations
111. Myasthenia gravis in association with allogeneic bone marrow transplantation: Clinical observations, therapeutic implications and review of literature
112. Myasthenia gravis without chronic GVHD after allogeneic bone marrow transplantation
113. Rituximab for myasthenia gravis developing after bone marrow transplantation
114. Treatment of posttransplant lymphoproliferative disorder with the anti-CD20 monoclonal antibody rituximab alone in an adult after liver transplantation: A new drug in therapy of patients with posttransplant lymphoproliferative disorder after solid organ transplantation?
115. IgM antibody-related polyneuropathies: B-cell depletion using Rituximab
116. Mycophenolate mofetil for myasthenia gravis: An open-label study
117. Chronic graft versus host disease presenting with polymyositis
118. Neurologic complications of graft-versus-host-disease
119. Myositis associated with graft-versus-host disease
120. Neurologic complications related to cardiac surgery
121. Cerebrovascular complications following cardiac transplantation
122. Cerebrovascular complications associated with the use of artificial circulatoryr support services
123. Neurologic problems in renal transplant recipients
124. Paraparesis after renal transplantation
125. Pancreas transplantation: A review
126. Long-term survival after liver transplantation in 4000 consecutive patients at a single center
127. Clinical intestinal transplantation: New perspectives and immunologic considerations
128. Posttransplant lymphoproliferative disorders in small bowel allograft recipients
129. Immune modulation in organ allograft recipients by single or multiple donor bone marrow infusions
130. Autologous blood stem cell transplantation as therapy for autoimmune diseases
131. Progressive deterioration of intellect and motor function occurring several decades after cranial irradiation
132. Cerebrospinal fluid after organ transplantation
133. Infection and xenotransplantation
134. Tissue engineering
135. Current status of genetic modification and cloning for xenografting
136. Review of Allo- and xenogeneic neural grafts in neurodegenerative disorders
137. Clinically significant drug interactions with cyclosporin. An update